22 Teams From Across Campus Explore Commercial Potential of New Ideas

More than 20 teams participated in the Polsky Center I-Corps program this academic year – all with new research and ideas addressing challenges across various industries. The goal of the…

Multi-Tissue Organoid Better Predicts Human Response to Drug Treatments: CellCipher

CellCipher has developed a new type of organoid model that captures nearly 70 different cell types to enable drug discovery and personalized medicine. In vitro human models, including organoids…

The Startup Connection: Researchers and Business Students Meet at Fall Collaboratorium

Connecting researchers with business expertise, the Fall 2023 Collaboratorium will feature teams participating in the Polsky I-Corps program in addition to startups from the Transform and Duality accelerators. The…

‘A Great Formula for Success’: Booth Alum Jennifer Fried Named CEO of Another UChicago Startup

An early-stage healthcare investor, founder, and operator, Chicago Booth alum Jennifer Fried, MBA ‘15, has taken on a new role – with a familiar path – at the helm of…

Polsky Center I-Corps Teams Test Commercialization Potential of Research

The Polsky I-Corps program helps scientists, researchers, and students test the commercial potential of their research and ideas. Supported with funding from the National Science Foundation (NSF) through the…

$1M Investment Moves Flow Medical Toward Commercialization for Its Novel Medical Device

University of Chicago startup Flow Medical is finalizing its product design – taking the next steps on its path to commercialization with a $1 million investment from a medical device…

Riptide Therapeutics Awarded $175,000 From George Shultz Innovation Fund

The George Shultz Innovation Fund (GSIF), managed by the Polsky Center for Entrepreneurship and Innovation, recently selected Riptide Therapeutics, a biopharmaceutical startup led by University of Chicago and Northwestern University…

ClostraBio Closes $4 Million Series A to Transform Intestinal Health with Plug-and-Play Drug Delivery Platform

University of Chicago spinout ClostraBio has closed a $4 million Series A-1 financing round to accelerate development of its lead candidate, expand its plug-n-play platform, and build out its team.…

Fermilab Engineer Scales Quantum Startup with Support from UChicago

Lismikro – taking its name from the Greek for “micro” – is developing innovative low-power microchip controllers to solve the hardware bottleneck and unleash the full potential of quantum computers.…

Met With Too Many Late-Stage Diagnoses, Doctors Create Novel Test to Earlier Detect Cancer in Your Saliva

OrisDX has developed a novel saliva-based molecular test to detect and diagnose oral cancer earlier – improving patient outcomes and saving lives. The Chicago-based startup was formed based on a…

AI, Life Sciences, Quantum Tech to Get Boost as Part of the Compass Accelerator’s Latest Cohort

The Polsky Center for Entrepreneurship and Innovation is pleased to announce that six teams have been selected for the latest cohort of Compass, a deep tech accelerator program for University…

OrisDX Wins 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers

UPDATE: The investment totals have been updated to reflect additional investment made in the days following the winner announcement. A startup developing saliva-based diagnostics to screen for oral cancers and…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept